MALARIA INFECTION
Clinical trials for MALARIA INFECTION explained in plain language.
Never miss a new study
Get alerted when new MALARIA INFECTION trials appear
Sign up with your email to follow new studies for MALARIA INFECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New malaria vaccine shows promise in first human trial
⭐️ VACCINE ⭐️ CompletedThis study tested a new malaria vaccine (PfSPZ-LARC2) in 75 healthy adults and children in Burkina Faso. The vaccine uses genetically weakened malaria parasites that grow in the liver but cannot cause blood infection. The goal was to see if it is safe and triggers a strong immune…
Matched conditions: MALARIA INFECTION
Phase: PHASE1 • Sponsor: Sanaria Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 07, 2026 18:38 UTC
-
One-Dose malaria shield? new combo drug aims to stop infection in its tracks
Prevention CompletedThis study tested whether a single dose of two drugs (M5717 and pyronaridine) can clear the malaria parasite from the blood and protect against future infection. It involved 192 adults and teens with no symptoms but confirmed malaria. The goal was to see how long protection lasts…
Matched conditions: MALARIA INFECTION
Phase: PHASE2 • Sponsor: Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany • Aim: Prevention
Last updated May 11, 2026 20:52 UTC